...
首页> 外文期刊>Journal of the American Medical Directors Association >Look-alike medications: a formula for possible morbidity and mortality in the long-term care facility.
【24h】

Look-alike medications: a formula for possible morbidity and mortality in the long-term care facility.

机译:相似药物:长期护理机构中可能的发病率和死亡率的公式。

获取原文
获取原文并翻译 | 示例

摘要

Medication errors remain an important cause of patient morbidity and mortality. Although all medications have the potential to induce unwanted adverse effects, data on the actual incidence and overall severity of preventable adverse drug reactions remains unknown. An Institute of Medicine report (Institute of Medicine. Preventing medication errors: Quality chasm series. Washington DC, National Academies Press. 2007-06-15) estimated that 1.5 million preventable adverse drug events occur annually in the US and that from 44,000 to 98,000 individuals die in hospitals annually from preventable medication errors. The types of medication errors of clinical relevance leading to moderate to severe outcomes are unfortunately numerous. Such errors would include wrong drug, wrong dose / wrong dose interval and represent the more serious form of a medication error. Institutionalized patients and those patients cared for in long-term care facilities appear to be at heightened risk for a medication error. These patients often receive multiple medications and suffer from variable degrees of cognitive impairment which complicates or negates patient-caregiver communication, one of the most important means to prevent medication errors. Moreover, the increasing financial constraints placed upon treatment facilities encourage the use of generic, rather than name brand medications by their pharmacy provider. While the use of bioequivalent generic medications is completely appropriate and can be very cost-effective, generic drug manufacturers are less often manufacturing their generic medications to look like the name brand drug. Rather, more and more generic medications are plain appearing with no resemblance whatsoever to the name brand product. This difference in drug appearance between the generic and the brand name product as well as differences in drug appearance between different generic drug manufacturers for the same medication represents another, important means by which patients may experience moderate to seriousconsequences from a medication error. We report such an experience where a patient in a long-term care facility received multi-day, excessive dosing of glipizide rather than her anti-spasticity medication, baclofen.
机译:用药错误仍然是患者发病和死亡的重要原因。尽管所有药物都有可能诱发不良副作用,但有关可预防药物不良反应的实际发生率和总体严重性的数据仍然未知。医学研究所的一份报告(医学研究所。预防用药错误:质量鸿沟系列。华盛顿特区,美国国家科学院出版社。2007-06-15)估计,美国每年发生150万可预防的不良药物事件,从44,000到98,000个人每年因可预防的用药错误而在医院死亡。不幸的是,导致中度至严重预后的临床相关用药错误类型很多。这样的错误将包括错误的药物,错误的剂量/错误的剂量间隔,并代表更严重的药物错误形式。住院患者和那些在长期护理机构中照顾过的患者,服药错误的风险似乎更高。这些患者通常会接受多种药物治疗,并患有不同程度的认知障碍,这会加重或消除患者与护理人员之间的沟通,这是预防用药错误的最重要手段之一。此外,对治疗设施的财务限制越来越大,促使药房提供商使用非专利药而不是名牌药。虽然生物等效的仿制药的使用是完全适当的,并且可能具有很高的成本效益,但仿制药制造商生产仿制药看起来像名牌药品的频率较低。相反,越来越多的非专利药物明显出现,与品牌产品完全没有相似之处。仿制药与品牌产品之间的药物外观差异以及同一药物在不同仿制药企业之间的药物外观差异代表了另一种重要的手段,使患者可能会因用药错误而遭受中度至严重的后果。我们报告了这样的经历:长期护理机构中的患者接受格列吡嗪的多日过量服药,而不是她的抗痉挛药巴氯芬。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号